Sign in / Join Now
ETFs & Funds
) says new look at data bolsters oral
is a winner. Buy and hold.
Add a reply...
Latest StockTalks »
people get BIIB breaking news and analysis by email alert.
Get email alerts on BIIB »
Get latest price
From other sites
The Good (Celgene) and Bad (Biogen) Ways to Deliver Drug Revenue Growth
at TheStreet (Thu, 11:23AM)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Biogen Inc. (BIIB) & Lead Plaintiff Deadline: December 23, 2016
at TheStreet (Thu, 10:15AM)
Key Takeaways from Biogen's Q3 Call: Tecfidera, Pipeline, Biosimilars
at Zacks.com (Thu, 8:57AM)
Pardon Me, but I Have a Few Things to Say... Vertex, Biogen, Ariad, Sarepta
at TheStreet (Wed, 11:54AM)
Biogen (BIIB) Beats on Q3 Earnings; Tecfidera Propels Sales
at Zacks.com (Wed, 8:54AM)